# Ultragenyx Pharmaceutical Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0d171594-5056-4796-a2e8-c666d6937243 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-28T14:40:03.785268+00:00 | | Last reviewed | 2026-09-28T14:40:03.785268+00:00 | ## Identity - Legal name: Ultragenyx Pharmaceutical Inc. - Display name: Ultragenyx Pharmaceutical Inc. ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Daniel G. Welch: Independent Chairman of the Board. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Amrit Ray: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3. - Amrit Ray, M.D.: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Corsee D. Sanders: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3. - Corsee D. Sanders, Ph.D.: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Deborah Dunsire: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3. - Deborah Dunsire, M.D.: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Emil D. Kakkis, M.D., Ph.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Matthew K. Fust: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:13. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3. - Michael Narachi: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:14. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3. - Shehnaaz Suliman: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:15. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3. - Shehnaaz Suliman, M.D.: Director. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Dennis Huang: Chief Technical Operations Officer and Gene Therapy and Executive Vice President. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Emil D. Kakkis, M.D., Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Eric Crombez, M.D.: Chief Medical Officer and Executive Vice President. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Erik Harris: Chief Commercial Officer and Executive Vice President. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Howard Horn: Chief Financial Officer, Corporate Strategy and Executive Vice President. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - John R. Pinion II: Chief Quality Officer and Executive Vice President of Translational Sciences. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. - Karah Parschauer: Chief Legal Officer & Corporate Affairs and Executive Vice President. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Ultragenyx Pharmaceutical Inc.. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1. ## Entity Status - Public listing published. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1. ## Published Fact - US. Claim: alpha:claim:company:0d171594-5056-4796-a2e8-c666d6937243:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc). - alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:2: [SEC DEF 14A 0001308179-26-000174](https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm). - alpha:evidence:company:0d171594-5056-4796-a2e8-c666d6937243:3: [DEF 14A lrare2026_def14a.htm](https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc) - [Public Markdown](https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc?format=jsonld) - MCP resource: `alpha://companies/ultragenyx-pharmaceutical-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible.